Neuroimmune Foundation is a 501(c)(3) non-profit organization dedicated to dramatically accelerating physician education of PANS, PANDAS, encephalitis, and related conditions; significantly improving outcomes for individuals impacted by these disorders through prompt diagnosis and insurance based care; providing meaningful support to families during their darkest days; catalyzing research at an unprecedented pace that will ultimately lead to lasting remission for all individuals impacted by these disorders.
What are Inflammatory Brain Disorders?
Individuals with inflammatory brain conditions often present with prominent neuropsychiatric symptoms that can be confusing for physicians and families alike. Our CME events feature nationally and internationally renowned experts skilled in diagnostic and therapeutic approaches who present a diverse range of emerging clinical and research challenges, insights, and advances in the field of inflammatory brain disorders. Presentations are carefully selected to familiarize attendees with rapidly developing research and to educate clinicians on the latest understanding of treatment options.
Check out our
Extensive Free Resources
Our extensive free resources for clinicians include Continuing Medical Education, access to top experts in the field through monthly case consultations, and quarterly compilation of relevant research. We provide clinicians the tools to confidently diagnose and treat immune-mediated neuropsychiatric illnesses and inflammatory brain conditions. Our Circle of Clinicians helps families to find a physician. Families are supported through therapist, physician, and researcher led webinars, local support meetings in locations around the world, a private Facebook group, and other resources.
Advocating on Behalf of Individuals with Neuroimmune and Inflammatory Brain Conditions
The Neuroimmune Foundation is a non-profit organization dedicated to dramatically accelerating physician education of neuroimmune and inflammatory brain conditions; significantly improving outcomes for individuals impacted by these disorders; providing meaningful support to families during their darkest days; and catalyzing research at an unprecedented pace.